These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

475 related articles for article (PubMed ID: 26238347)

  • 21. Cholecalciferol loading dose guideline for vitamin D-deficient adults.
    van Groningen L; Opdenoordt S; van Sorge A; Telting D; Giesen A; de Boer H
    Eur J Endocrinol; 2010 Apr; 162(4):805-11. PubMed ID: 20139241
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vitamin D deficiency and associated factors in hemodialysis patients.
    Jean G; Charra B; Chazot C
    J Ren Nutr; 2008 Sep; 18(5):395-9. PubMed ID: 18721733
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Daily oral 25-hydroxycholecalciferol supplementation for vitamin D deficiency in haemodialysis patients: effects on mineral metabolism and bone markers.
    Jean G; Terrat JC; Vanel T; Hurot JM; Lorriaux C; Mayor B; Chazot C
    Nephrol Dial Transplant; 2008 Nov; 23(11):3670-6. PubMed ID: 18579534
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Cholecalciferol supplementation improves secondary hyperparathyroidism control in hemodialysis patients].
    Massimetti C; Bellasi A; Feriozzi S
    G Ital Nefrol; 2020 Jun; 37(3):. PubMed ID: 32530156
    [No Abstract]   [Full Text] [Related]  

  • 25. Prevalence of vitamin D [25(OH)D] deficiency and effects of supplementation with ergocalciferol (vitamin D2) in stage 5 chronic kidney disease patients.
    Blair D; Byham-Gray L; Lewis E; McCaffrey S
    J Ren Nutr; 2008 Jul; 18(4):375-82. PubMed ID: 18558303
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Modified-release oral calcifediol corrects vitamin D insufficiency with minimal CYP24A1 upregulation.
    Petkovich M; Melnick J; White J; Tabash S; Strugnell S; Bishop CW
    J Steroid Biochem Mol Biol; 2015 Apr; 148():283-9. PubMed ID: 25446887
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy and safety of a short course of very-high-dose cholecalciferol in hemodialysis.
    Wasse H; Huang R; Long Q; Singapuri S; Raggi P; Tangpricha V
    Am J Clin Nutr; 2012 Feb; 95(2):522-8. PubMed ID: 22237061
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of cholecalciferol on parathyroid hormone and vitamin D levels in chronic kidney disease.
    Basturk T; Unsal A; Ulas T
    Minerva Urol Nefrol; 2011 Dec; 63(4):287-92. PubMed ID: 21996984
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 25-Hydroxyvitamin D response to cholecalciferol supplementation in hemodialysis.
    Armas LA; Andukuri R; Barger-Lux J; Heaney RP; Lund R
    Clin J Am Soc Nephrol; 2012 Sep; 7(9):1428-34. PubMed ID: 22798536
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Oral calcitriol versus oral alfacalcidol for the treatment of secondary hyperparathyroidism in patients receiving hemodialysis: a randomized, crossover trial.
    Moe S; Wazny LD; Martin JE
    Can J Clin Pharmacol; 2008; 15(1):e36-43. PubMed ID: 18192704
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cinacalcet HCl, an oral calcimimetic agent for the treatment of secondary hyperparathyroidism in hemodialysis and peritoneal dialysis: a randomized, double-blind, multicenter study.
    Lindberg JS; Culleton B; Wong G; Borah MF; Clark RV; Shapiro WB; Roger SD; Husserl FE; Klassen PS; Guo MD; Albizem MB; Coburn JW
    J Am Soc Nephrol; 2005 Mar; 16(3):800-7. PubMed ID: 15689407
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Early initiation of cinacalcet for the treatment of secondary hyperparathyroidism in hemodialysis patients: a three-year clinical experience.
    Lucchi L; Carboni C; Stipo L; Malaguti V; Ferrari F; Graziani R; Arletti S; Graziosi C
    Artif Organs; 2011 Dec; 35(12):1186-93. PubMed ID: 21848793
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Changes in mineral metabolism in stage 3, 4, and 5 chronic kidney disease (not on dialysis)].
    Lorenzo Sellares V; Torregrosa V
    Nefrologia; 2008; 28 Suppl 3():67-78. PubMed ID: 19018742
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of a single, high oral dose of 25-hydroxycholecalciferol on the mineral metabolism markers in hemodialysis patients.
    Merino JL; Teruel JL; Fernández-Lucas M; Villafruela JJ; Bueno B; Gomis A; Paraíso V; Quereda C
    Ther Apher Dial; 2015 Jun; 19(3):212-9. PubMed ID: 25656524
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pilot Study Evaluating Efficacy of 2 Regimens for Hypovitaminosis D Repletion in Pediatric Inflammatory Bowel Disease.
    Simek RZ; Prince J; Syed S; Sauer CG; Martineau B; Hofmekler T; Freeman AJ; Kumar A; McElhanon BO; Schoen BT; Tenjarla G; McCracken C; Ziegler TR; Tangpricha V; Kugathasan S
    J Pediatr Gastroenterol Nutr; 2016 Feb; 62(2):252-8. PubMed ID: 26196201
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparisons between oral pulse alfacalcidol therapy and daily therapy in maintenance hemodialysis patients with secondary hyperparathyroidism: a randomized, controlled, and multicenter study.
    Gu Y; Ding F; Chen N; Mei CL; Qian JQ; Wang XY; Shi W; Hou FF; Li XW; Wang M; Chen YP
    Ren Fail; 2005; 27(2):205-12. PubMed ID: 15807187
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of a single oral dose of 600,000 IU of cholecalciferol on serum calciotropic hormones in young subjects with vitamin D deficiency: a prospective intervention study.
    Cipriani C; Romagnoli E; Scillitani A; Chiodini I; Clerico R; Carnevale V; Mascia ML; Battista C; Viti R; Pileri M; Eller-Vainicher C; Minisola S
    J Clin Endocrinol Metab; 2010 Oct; 95(10):4771-7. PubMed ID: 20660032
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of two different vitamin D supplementation regimens with oral calcifediol in kidney transplant patients.
    Barros X; Rodríguez NY; Fuster D; Rodas L; Esforzado N; Mazza A; Rubello D; Campos F; Tapias A; Torregrosa JV
    J Nephrol; 2016 Oct; 29(5):703-9. PubMed ID: 26454858
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cholecalciferol v. ergocalciferol for 25-hydroxyvitamin D (25(OH)D) repletion in chronic kidney disease: a randomised clinical trial.
    Wetmore JB; Kimber C; Mahnken JD; Stubbs JR
    Br J Nutr; 2016 Dec; 116(12):2074-2081. PubMed ID: 28065190
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Response of Vitamin D Concentration to Vitamin D3 Administration in Older Adults without Sun Exposure: A Randomized Double-Blind Trial.
    Schwartz JB; Kane L; Bikle D
    J Am Geriatr Soc; 2016 Jan; 64(1):65-72. PubMed ID: 26782853
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.